Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dorothy J. Margolskee"'
Autor:
Jørgen Bo Rasmussen, Philip Tagari, Vanessa C. Williams, Dorothy J. Margolskee, Karl-Erik Andersson, Lars-Olof Eriksson
Publikováno v:
Journal of Allergy and Clinical Immunology. 90:193-201
We have tested the hypothesis that leukotriene D 4 (LTD 4 ) receptor activation is involved in the development of antigen-induced bronchoconstriction. In two studies, patients with asthma received infusions of placebo or MAT-571, a potent and specifi
Autor:
Dorothy J. Margolskee
Publikováno v:
Annals of the New York Academy of Sciences. 629:148-156
Publikováno v:
Biology of Blood and Marrow Transplantation. 19(2):S299-S300
Publikováno v:
Biology of Blood and Marrow Transplantation. 19:S299
Autor:
Thorir D. Bjornsson, Dorothy J. Margolskee, Vanessa C. Williams, Charles C. Lin, Jules I. Schwartz, J. Douglas Rogers, John Y.-K. Hsieh
The influence of dose and food on the pharmacokinetic profile of orally administered verlukast, a leukotriene D4 receptor antagonist, was investigated in 12 healthy male volunteers. This was an open, four-period, single dose, randomised, crossover de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::367bb5177720088543807da69fd19d0c
https://europepmc.org/articles/PMC1364621/
https://europepmc.org/articles/PMC1364621/
Autor:
Karl-Erik Andersson, J. B. Rasmussen, Dorothy J. Margolskee, Philip Tagari, L.-O. Eriksson, Y. Girard
Publikováno v:
Allergy. 47(6)
Leukotriene (LT) E4 represents the major LT metabolite in man, and its urinary excretion can be used as an indirect marker of systemic LTC4 and/or LTD4 synthesis and release. In the present study LTE4 excretion was monitored for 24 h in 12 atopic pat
Autor:
Dorothy J. Margolskee, William W. Busse, Robert K. Bush, Vanessa C. Williams, Joseph N. Gaddy
Publikováno v:
The American review of respiratory disease. 146(2)
The sulfidopeptide leukotrienes LTC4, LTD4, and LTE4 can cause airway smooth muscle contraction and have been implicated in the pathophysiology of asthma. MK-571 is a selective, potent LTD4 receptor antagonist that could attenuate airway obstruction
Autor:
Marcel E. Van Der Straeten, Johan Kips, Inge De Lepeleire, Guy Joos, Agnes Buntinx, Romain Pauwels, Dorothy J. Margolskee
Publikováno v:
The American review of respiratory disease. 144(3 Pt 1)
MK-571 is a novel leukotriene D4/E4 (LTD4/E4) receptor antagonist. The ability of MK-571 to inhibit LTD4-induced bronchoconstriction was examined both in six healthy volunteers and in six asthmatic subjects in a double-blind, placebo-controlled, rand
Autor:
Dorothy J. Margolskee, Jules I. Schwartz, Richard M. Watson, Paul M. O'Byrne, Vanessa C. Williams, Patrick J. Manning
Publikováno v:
The New England journal of medicine. 323(25)
Exercise is a common stimulus of bronchoconstriction in subjects with asthma, who also have bronchoconstriction after inhaling the sulfidopeptide leukotriene D4 (LTD4). The purpose of this study was to investigate the importance of LTD4 as a mediator
Autor:
Vanessa C. Williams, Lars-Olof Eriksson, K. E. Andersson, Dorothy J. Margolskee, J. B. Rasmussen
Publikováno v:
Annals of the New York Academy of Sciences. 629:436-436